Generac's Kyle Andrew Raabe sells shares at $212.57

The common-stock sales and acquisition by the President, Home Power Gen., were under a Rule 10b5-1 plan adopted May 5, 2026.

Rhea-AI Filing Summary

Generac Holdings Inc. President, Home Power Gen. Kyle Andrew Raabe exercised options for 213 shares of common stock on October 2, 2026, at a $102.415 exercise price, and sold those 213 shares at $212.57 per share. He also sold 390 shares at $212.57 per share. The common-stock acquisition and reported sales were made under a Rule 10b5-1 plan adopted May 5, 2026. His reported post-transaction position was 424 shares underlying stock options.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Raabe Kyle Andrew

Role President, Home Power Gen.

Sold 603 shs ($128K)

Approx. gross sale proceeds $128K

Approx. exercise cost $22K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F3	213	$0.00	$0.00
Sale	Common Stock F1, F2	390	$212.57	$83K
Exercise	Common Stock F1	213	$102.415	$22K
Sale	Common Stock F1	213	$212.57	$45K

Holdings After Transaction: Stock Option (Right to Buy) — 424 contracts (Direct); Common Stock — 9,966 shares (Direct)

Footnotes (3)

1. F1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026
2. F2. Multiple lots for the same price for this order have been combined.
3. F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Key Figures

Shares acquired through option exercise: 213 shares Exercise price: $102.415 per share Shares sold from exercised options: 213 shares +5 more

8 metrics

Shares acquired through option exercise 213 shares October 2, 2026

Exercise price $102.415 per share Option exercise on October 2, 2026

Shares sold from exercised options 213 shares October 2, 2026

Additional shares sold 390 shares October 2, 2026

Sale price $212.57 per share Reported sales on October 2, 2026

Post-transaction shares underlying stock options 424 shares Reported after the October 2, 2026 option transaction

Plan adoption date May 5, 2026 Rule 10b5-1 plan referenced for the common-stock acquisition and sales

Option expiration date March 1, 2030 Reported stock-option entry

Key Terms

Rule 10b5-1(c) plan, graded vesting schedule, vesting tranche, Stock Option (Right to Buy)

4 terms

Rule 10b5-1(c) plan regulatory

"Adoption date of referenced 10b5-1(c) plan is"

graded vesting schedule financial

"Grant has a graded vesting schedule."

vesting tranche financial

"Date exercisable will vary for each vesting tranche."

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GNRC shares did Kyle Andrew Raabe sell, and at what price?

Raabe reported sales of 213 shares and 390 shares, each at $212.57 per share. The reported sales were made under a Rule 10b5-1 plan adopted May 5, 2026.

When do Kyle Andrew Raabe's reported stock options expire?

The reported stock options have an expiration date of March 1, 2030.

What did GNRC's Form 4 report about the option vesting schedule?

The grant has a graded vesting schedule, and the date exercisable varies for each vesting tranche.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 04:13 PM Accepted by SEC EDGAR 10/06/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raabe Kyle Andrew

(Last) (First) (Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA WISCONSIN 53189

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Home Power Gen.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2026		S(1)(2)		390	D	$212.57	9,966	D
Common Stock	10/02/2026		M(1)		213	A	$102.415	10,179	D
Common Stock	10/02/2026		S(1)		213	D	$212.57	9,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$102.415	10/02/2026		M			213	(3)	03/01/2030	Common Stock	213	$0	424	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026

2. Multiple lots for the same price for this order have been combined.

3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)